Allscripts Healthcare Solutions Inc (MDRX) : Blue Harbour Group reduced its stake in Allscripts Healthcare Solutions Inc by 17.32% during the most recent quarter end. The investment management company now holds a total of 9,309,695 shares of Allscripts Healthcare Solutions Inc which is valued at $97,286,313 after selling 1,950,000 shares in Allscripts Healthcare Solutions Inc , the firm said in a disclosure report filed with the SEC on Nov 14, 2016.Allscripts Healthcare Solutions Inc makes up approximately 3.88% of Blue Harbour Group’s portfolio.
Other Hedge Funds, Including , Allianz Asset Management Ag boosted its stake in MDRX in the latest quarter, The investment management firm added 353,460 additional shares and now holds a total of 364,530 shares of Allscripts Healthcare Solutions Inc which is valued at $3,809,339. Allscripts Healthcare Solutions Inc makes up approx 0.01% of Allianz Asset Management Ag’s portfolio. Victory Capital Management Inc added MDRX to its portfolio by purchasing 2,721,313 company shares during the most recent quarter which is valued at $31,512,805. Allscripts Healthcare Solutions Inc makes up approx 0.09% of Victory Capital Management Inc’s portfolio. Old Mutual Global Investors (uk) Ltd. sold out all of its stake in MDRX during the most recent quarter. The investment firm sold 48,372 shares of MDRX which is valued $580,948.California Public Employees Retirement System reduced its stake in MDRX by selling 51,000 shares or 8.36% in the most recent quarter. The Hedge Fund company now holds 558,700 shares of MDRX which is valued at $7,017,272. Allscripts Healthcare Solutions Inc makes up approx 0.01% of California Public Employees Retirement System’s portfolio.
Allscripts Healthcare Solutions Inc closed down -0.04 points or -0.37% at $10.85 with 22,69,226 shares getting traded on Monday. Post opening the session at $10.99, the shares hit an intraday low of $10.84 and an intraday high of $11.37 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Allscripts Healthcare Solutions Inc reported $0.14 EPS for the quarter, missing the analyst consensus estimate by $ -0.01 based on the information available during the earnings call on Nov 3, 2016. Analyst had a consensus of $0.15. The company had revenue of $392.40 million for the quarter, compared to analysts expectations of $414.18 million. The company’s revenue was up 10.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.13 EPS.
Many Wall Street Analysts have commented on Allscripts Healthcare Solutions Inc. Allscripts Healthcare Solutions Inc was Resumed by JP Morgan to “Overweight” on Oct 28, 2016. Leerink Partners Upgraded Allscripts Healthcare Solutions Inc on Aug 23, 2016 to ” Outperform”, Price Target of the shares are set at $17.
Allscripts Healthcare Solutions Inc. is engaged in engaged in delivering Information Technology (IT) and services. The Company sells its solutions to physicians hospitals governments health systems health plans retail clinics retail pharmacies pharmacy benefit managers and post-acute organizations such as home health and hospice agencies. The Company operates through three segments: Clinical and Financial Solutions Population Health and Managed Services. The Companys solutions enable healthcare professionals with the data insights and connectivity. The Company offers Ambulatory Solutions Acute Care Solutions Population Health Management Solutions and services. Ambulatory solutions include Allscripts TouchWorks HER and Allscripts Professional HER among others. The Companys acute care offers clinical access financial and departmental solutions. The Company designs its population health management solutions for hospitals health systems among others.